HNF1A-AS1 Regulates Cell Migration, Invasion and Glycolysis via Modulating miR-124/MYO6 in Colorectal Cancer Cells

References

• Baena R, Salinas P. Diet and colorectal cancer. Maturitas. 2015;80(3):258–264. doi:10.1016/j.maturitas.2014.12.01725619144
   PubMed Web of Science ®Google Scholar
• Zhao P, Dai M, Chen W, et al. Cancer trends in China. Jpn J Clin Oncol. 2010;40(4):281–285. doi:10.1093/jjco/hyp18720085904
   PubMed Web of Science ®Google Scholar
• Cao J. The functional role of long non-coding RNAs and epigenetics. Biol Proced Online. 2014;16(1):42. doi:10.1186/1480-9222-16-11
   Google Scholar
• Jiang C, Li X, Zhao H, et al. Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis. Mol Cancer. 2016;15(1):62. doi:10.1186/s12943-016-0545-z27686732
   PubMed Web of Science ®Google Scholar
• Kitagawa M, Kitagawa K, Kotake Y, et al. Cell cycle regulation by long non-coding RNAs. Cell Mol Life Sci. 2013;70(24):4785–4794. doi:10.1007/s00018-013-1423-023880895
   PubMed Web of Science ®Google Scholar
• Li Z, Yu X, Shen J. ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers. Tumour Biol. 2016;37(5):5657–5661. doi:10.1007/s13277-016-4808-526753962
   PubMedGoogle Scholar
• Sun K, Wu D, Chen S, et al. LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway. Apoptosis. 2017;22(12):1543–1552. doi:10.1007/s10495-017-1426-729094270
   PubMed Web of Science ®Google Scholar
• Qin J, Ning H, Yao Z, et al. LncRNA Uc.173 is a key molecule for the regulation of lead-induced renal tubular epithelial cell apoptosis. Biomed Pharmacother. 2018;100:101–107. doi:10.1016/j.biopha.2018.01.11229425744
   PubMed Web of Science ®Google Scholar
• Xiao-Yun HE, Chun-Lin OU, Xiao YH, et al. Inhibitory effect of saxagliptin on high glucose-induced overexpression of LncRNA-MALAT1 in endothelial cells. J Med Postgrad. 2016;29(9):902–905.
   Google Scholar
• Zhang Y, Zhang X, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013;51(6):792–806. doi:10.1016/j.molcel.2013.08.01724035497
   PubMed Web of Science ®Google Scholar
• Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–1109. doi:10.1016/j.bbagrm.2014.08.01225159663
   PubMed Web of Science ®Google Scholar
• Wu Q, Meng W, Jie Y, et al. LncRNA MALAT1 induces colon cancer development by regulating miR‐129‐5p/HMGB1 axis. J Cell Physiol. 2018;233(9):6750–6757. doi:10.1002/jcp.2638329226325
   PubMed Web of Science ®Google Scholar
• Zhang G, Li S, Lu J, et al. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer. Mol Cancer. 2018;17(1):87. doi:10.1186/s12943-018-0829-629720189
   PubMedGoogle Scholar
• Zhu H, Yu J, Zhu H, et al. Identification of key lncRNAs in colorectal cancer progression based on associated protein–protein interaction analysis. World J Surg Oncol. 2017;15(1):153. doi:10.1186/s12957-017-1211-728797257
   PubMedGoogle Scholar
• Liu T, Han Z, Li H, et al. LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3. Mol Cancer. 2018;17(1):118. doi:10.1186/s12943-018-0873-230098595
   PubMed Web of Science ®Google Scholar
• Han P, Li J, Zhang B, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol Cancer. 2017;16(1):9. doi:10.1186/s12943-017-0583-128086904
   PubMed Web of Science ®Google Scholar
• Shen X, Bai Y, Luo B, et al. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer. Biol Res. 2017;50(1):32. doi:10.1186/s40659-017-0136-528969673
   PubMedGoogle Scholar
• Wu Y, Liu H, Shi X, et al. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget. 2015;6(11):9160–9172. doi:10.18632/oncotarget.324725863539
   PubMedGoogle Scholar
• Zhu W, Zhuang P, Song W, et al. Knockdown of lncRNA HNF1A-AS1 inhibits oncogenic phenotypes in colorectal carcinoma. Mol Med Rep. 2017;16(4):4694–4700. doi:10.3892/mmr.2017.717528791380
   PubMed Web of Science ®Google Scholar
• Zhang G, An X, Zhao H, et al. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer. Biomed Pharmacother. 2018;98:594–599. doi:10.1016/j.biopha.2017.12.08029289833
   PubMed Web of Science ®Google Scholar
• Feng Z, Wang B. Long non-coding RNA HNF1A-AS1 promotes cell viability and migration in human bladder cancer. Oncol Lett. 2018;15(4):4535–4540. doi:10.3892/ol.2018.787829541223
   PubMed Web of Science ®Google Scholar
• Ding C, Yin C, Chen S, et al. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1. Mol Cancer. 2018;17(1):63. doi:10.1186/s12943-018-0813-129466992
   PubMedGoogle Scholar
• Yang X, Song JH, Cheng Y, et al. Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut. 2014;63(6):881–890. doi:10.1136/gutjnl-2013-30526624000294
   PubMed Web of Science ®Google Scholar
• Zhao H, Hou W, Tao J, et al. Upregulation of lncRNA HNF1A-AS1 promotes cell proliferation and metastasis in osteosarcoma through activation of the Wnt/β-catenin signaling pathway. Am J Transl Res. 2016;8(8):3503–3512.27648140
   PubMed Web of Science ®Google Scholar
• Gong W, Tian M, Qiu H, et al. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma. Cancer Biomarkers. 2017;20(4):417–424. doi:10.3233/CBM-17017928946548
   PubMed Web of Science ®Google Scholar
• Zhuang C, Zheng L, Wang P. Prognostic role of long non-coding RNA HNF1A-AS1 in Chinese cancer patients: a meta-analysis. Onco Targets Ther. 2018;11:5325–5332. doi:10.2147/OTT.S16357530214238
   PubMed Web of Science ®Google Scholar
• Liotta LA. Tumor invasion and metastases—role of the extracellular matrix: rhoads memorial award lecture. Cancer Res. 1986;46(1):1–7.2998604
   PubMed Web of Science ®Google Scholar
• Ridley AJ. Rho GTPases and cell migration. J Cell Sci. 2001;114(Pt 15):2713–2722.11683406
   PubMed Web of Science ®Google Scholar
• Eades G, Zhang Y, Li Q, et al. Long non-coding RNAs in stem cells and cancer. World J Clin Oncol. 2014;5(2):134–141. doi:10.5306/wjco.v5.i2.13424829860
   PubMedGoogle Scholar
• Xu S, Kong D, Chen Q, et al. Oncogenic long noncoding RNA landscape in breast cancer. Mol Cancer. 2017;16(1):129. doi:10.1186/s12943-017-0696-628738804
   PubMed Web of Science ®Google Scholar
• Chaofeng TU. The interaction between lncRNA and microRNA contributes to tumor. Chin J Biochem Mol Biol. 2013;29(11):1029–1034.
   Google Scholar
• Zhou Y, Chen Y, Ding W, et al. LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR‐96/FOXO3. IUBMB Life. 2018;70(4):276–290. doi:10.1002/iub.v70.429500870
   PubMed Web of Science ®Google Scholar
• Ye Y, Gao X, Yang N. LncRNA ZFAS1 promotes cell migration and invasion of fibroblast-like synoviocytes by suppression of miR-27a in rheumatoid arthritis. Hum Cell. 2018;31(1):14–21. doi:10.1007/s13577-017-0179-528721682
   PubMed Web of Science ®Google Scholar
• Zhao W, Fu H, Zhang S, et al. LncRNA SNHG16 drives proliferation, migration, and invasion of hemangioma endothelial cell through modulation of miR‐520d‐3p/STAT3 axis. Cancer Med. 2018;7(7):3311–3320. doi:10.1002/cam4.2018.7.issue-7
   PubMed Web of Science ®Google Scholar
• Lin J, Shi Z, Yu Z, et al. LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A. Biomed Pharmacother. 2017;98:433. doi:10.1016/j.biopha.2017.12.05829278853
   PubMed Web of Science ®Google Scholar
• Silber J, Lim DA, Petritsch C, et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008;6(1):14. doi:10.1186/1741-7015-6-1418577219
   PubMedGoogle Scholar
• Taniguchi K, Sugito N, Kumazaki M, et al. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer. Cancer Lett. 2015;363(1):17–27. doi:10.1016/j.canlet.2015.03.02625818238
   PubMed Web of Science ®Google Scholar
• Zhou L, Xu Z, Ren X, et al. MicroRNA-124 (MiR-124) inhibits cell proliferation, metastasis and invasion in colorectal cancer by downregulating Rho-Associated Protein Kinase 1(ROCK1). Cell Physiol Biochem. 2016;38(5):1785–1795. doi:10.1159/00044311727159971
   PubMedGoogle Scholar
• Zhu J, Zhang R, Yang D, et al. Knockdown of long non-coding RNA XIST inhibited doxorubicin resistance in colorectal cancer by upregulation of miR-124 and downregulation of SGK1. Cell Physiol Biochem. 2018;51(1):113–128. doi:10.1159/00049516830439718
   PubMedGoogle Scholar
• Wang Z, Ying M, Wu Q, et al. Overexpression of myosin VI regulates gastric cancer cell progression. Gene. 2016;593(1):100–109. doi:10.1016/j.gene.2016.08.01527515005
   PubMed Web of Science ®Google Scholar
• Wang D, Zhu L, Liao M, et al. MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40. Oncol Rep. 2016;36(3):1285–1292. doi:10.3892/or.2016.491027431378
   PubMed Web of Science ®Google Scholar
• Wang H, Wang B, Zhu W, et al. Lentivirus-mediated knockdown of myosin VI inhibits cell proliferation of breast cancer cell. Cancer Biother Radiopharm. 2015;30(8):330–335. doi:10.1089/cbr.2014.175926407123
   PubMed Web of Science ®Google Scholar
• You W, Tan G, Sheng N, et al. Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer. Acta Biochim Biophys Sin (Shanghai). 2016;48(5):430–436. doi:10.1093/abbs/gmw02027044563
   PubMed Web of Science ®Google Scholar
• Gershon TR, Crowther AJ, Tikunov AP, et al. Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma. Cancer Metab. 2013;1(1):2. doi:10.1186/2049-3002-1-224280485
   PubMedGoogle Scholar
• Ros S, Schulze A. Glycolysis back in the limelight: systemic targeting of HK2 blocks tumor growth. Cancer Discov. 2013;3(10):1105–1107. doi:10.1158/2159-8290.CD-13-056524124231
   PubMed Web of Science ®Google Scholar
• Wang H, Wang L, Zhang Y, et al. Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell Int. 2016;16(1):9. doi:10.1186/s12935-016-0280-y26884725
   PubMedGoogle Scholar
• Wolf A, Agnihotri S, Micallef J, et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med. 2011;208(2):313–326. doi:10.1084/jem.2010147021242296
   PubMed Web of Science ®Google Scholar
• Li Z, Li X, Wu S, et al. Long non‐coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR–STAT3/microRNA143 pathway. Cancer Sci. 2014;105(8):951–955. doi:10.1111/cas.2014.105.issue-824890811
   PubMed Web of Science ®Google Scholar
• Kong X, Hu S, Sun Z, et al. Regulation of aerobic glycolysis by long non-coding RNAs in cancer. Biochem Biophys Res Commun. 2016;479(1):28–32. doi:10.1016/j.bbrc.2016.09.00727596968
   PubMed Web of Science ®Google Scholar
• Li X, Zhao Q, Qi J, et al. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma. Int J Oncol. 2018;53(2):551–566. doi:10.3892/ijo.2018.441829845188
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang Q, Zhang J, et al. Long non-coding RNA MALAT1 contributes to cell apoptosis by sponging miR-124 in parkinson disease. Cell Biosci. 2017;7(1):19. doi:10.1186/s13578-017-0147-528439401
   PubMedGoogle Scholar
• Luo F, Liu X, Ling M, et al. The lncRNA MALAT1, acting through HIF-1α stabilization, enhances arsenite-induced glycolysis in human hepatic L-02 cells. Biochim Biophys Acta. 2016;1862(9):1685–1695. doi:10.1016/j.bbadis.2016.06.00427287256
   PubMed Web of Science ®Google Scholar